Annual ROE
-782.60%
-700.47%-852.88%
December 31, 2022
Summary
- As of February 24, 2025, BLPH annual return on equity is -782.60%, with the most recent change of -700.47% (-852.88%) on December 31, 2022.
- During the last 3 years, BLPH annual ROE has fallen by -413.15% (-111.83%).
Performance
BLPH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-164.63%
+24.79%+13.09%
September 30, 2023
Summary
- As of February 24, 2025, BLPH quarterly return on equity is -164.63%, with the most recent change of +24.79% (+13.09%) on September 30, 2023.
- Over the past year, BLPH quarterly ROE has stayed the same.
Performance
BLPH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BLPH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -852.9% | 0.0% |
| 3 y3 years | -111.8% | 0.0% |
| 5 y5 years | -137.0% | 0.0% |
BLPH ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +852.9% | at low | +156.4% | +25.4% |
| 5 y | 5-year | +1110.5% | at low | +178.5% | +72.6% |
| alltime | all time | -137.0% | at low | -108.5% | +1163.6% |
Bellerophon Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -164.63%(-13.1%) |
| Jun 2023 | - | -189.42%(+36.8%) |
| Mar 2023 | - | -138.45%(-33.0%) |
| Dec 2022 | -782.60%(+852.9%) | -206.51%(+55.5%) |
| Sep 2022 | - | -132.79%(+35.0%) |
| Jun 2022 | - | -98.35%(+28.4%) |
| Mar 2022 | - | -76.59%(+19.3%) |
| Dec 2021 | -82.13%(+27.0%) | -64.20%(-4.9%) |
| Sep 2021 | - | -67.54%(+0.4%) |
| Jun 2021 | - | -67.29%(+13.8%) |
| Mar 2021 | - | -59.11%(-16.5%) |
| Dec 2020 | -64.65%(-82.5%) | -70.82%(-10.6%) |
| Sep 2020 | - | -79.24%(-23.2%) |
| Jun 2020 | - | -103.22%(-63.7%) |
| Mar 2020 | - | -284.21%(+75.2%) |
| Dec 2019 | -369.45%(-606.2%) | -162.25%(+32.4%) |
| Sep 2019 | - | -122.52%(-271.1%) |
| Jun 2019 | - | 71.59%(-188.9%) |
| Mar 2019 | - | -80.56%(-115.9%) |
| Dec 2018 | 72.98% | 505.89%(-73.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | 1934.49%(-193.0%) |
| Jun 2018 | - | -2080.30%(+139.0%) |
| Mar 2018 | - | -870.54%(-48.0%) |
| Dec 2017 | 2113.26%(-1696.6%) | -1674.73%(+270.3%) |
| Sep 2017 | - | -452.29%(+17.3%) |
| Jun 2017 | - | -385.44%(+52.6%) |
| Mar 2017 | - | -252.57%(+112.0%) |
| Dec 2016 | -132.36%(-13.6%) | -119.14%(+1.0%) |
| Sep 2016 | - | -117.96%(-0.9%) |
| Jun 2016 | - | -119.02%(+7.0%) |
| Mar 2016 | - | -111.28%(+10.5%) |
| Dec 2015 | -153.15%(-41.1%) | -100.75%(-7.9%) |
| Sep 2015 | - | -109.34%(-11.0%) |
| Jun 2015 | - | -122.90%(-15.0%) |
| Mar 2015 | - | -144.67%(-29.6%) |
| Dec 2014 | -260.16%(-166.0%) | -205.64%(-68.7%) |
| Sep 2014 | - | -657.75%(-314.8%) |
| Jun 2014 | - | 306.28%(+54.1%) |
| Mar 2014 | - | 198.80%(+86.5%) |
| Dec 2013 | 393.96%(-5.3%) | 106.60% |
| Dec 2012 | 415.86% | - |
FAQ
- What is Bellerophon Therapeutics annual return on equity?
- What is the all time high annual ROE for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics annual ROE year-on-year change?
- What is Bellerophon Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly ROE year-on-year change?
What is Bellerophon Therapeutics annual return on equity?
The current annual ROE of BLPH is -782.60%
What is the all time high annual ROE for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high annual return on equity is 2113.26%
What is Bellerophon Therapeutics annual ROE year-on-year change?
Over the past year, BLPH annual return on equity has changed by -700.47% (-852.88%)
What is Bellerophon Therapeutics quarterly return on equity?
The current quarterly ROE of BLPH is -164.63%
What is the all time high quarterly ROE for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high quarterly return on equity is 1934.49%
What is Bellerophon Therapeutics quarterly ROE year-on-year change?
Over the past year, BLPH quarterly return on equity has changed by 0.00% (0.00%)